Oligomerix
Bronx
About Oligomerix
Oligomerix is a biopharmaceutical company founded in 2006 by co-founders Eliot J. Davidowitz and James Moe. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer's and other neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $18.1M
- Funding stage: Early Stage Venture
- Last round: Grant (Nov 2025)
- Website: oligomerix.com
- Phone: (212) 568-0365
Industries & Categories
Biotechnology, Ediscovery, Medical
Social Profiles
Canonical: https://fsome.com/organization/oligomerix-53190 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.